These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1504038)

  • 61. Halogen bonding for rational drug design and new drug discovery.
    Lu Y; Liu Y; Xu Z; Li H; Liu H; Zhu W
    Expert Opin Drug Discov; 2012 May; 7(5):375-83. PubMed ID: 22462734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A.
    Cho JH; Kim DH; Lee KJ; Kim DH; Choi KY
    Biochemistry; 2001 Aug; 40(34):10197-203. PubMed ID: 11513597
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of the inhibitor complexes of cobalt carboxypeptidase A by electron paramagnetic resonance spectroscopy.
    Martinelli RA; Hanson GR; Thompson JS; Holmquist B; Pilbrow JR; Auld DS; Vallee BL
    Biochemistry; 1989 Mar; 28(5):2251-8. PubMed ID: 2541781
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Environment and conformation dependent sensitivity of the arsanilazotyrosine-248 carboxypeptidase A chromophore.
    Johansen JT; Vallee BL
    Biochemistry; 1975 Feb; 14(4):649-60. PubMed ID: 234737
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ab initio study of the complexes of halogen-containing molecules RX (X=Cl, Br, and I) and NH3: towards understanding the nature of halogen bonding and the electron-accepting propensities of covalently bonded halogen atoms.
    Zou JW; Jiang YJ; Guo M; Hu GX; Zhang B; Liu HC; Yu QS
    Chemistry; 2005 Jan; 11(2):740-51. PubMed ID: 15584077
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design of new immobilized-stabilized carboxypeptidase a derivative for production of aromatic free hydrolysates of proteins.
    Tardioli PW; Fernández-Lafuente R; Guisán JM; Giordano RL
    Biotechnol Prog; 2003; 19(2):565-74. PubMed ID: 12675602
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strong and weak hydrogen bonds in the protein-ligand interface.
    Panigrahi SK; Desiraju GR
    Proteins; 2007 Apr; 67(1):128-141. PubMed ID: 17206656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Halogen atoms in the modern medicinal chemistry: hints for the drug design.
    Hernandes MZ; Cavalcanti SM; Moreira DR; de Azevedo Junior WF; Leite AC
    Curr Drug Targets; 2010 Mar; 11(3):303-14. PubMed ID: 20210755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting Protein Pockets with Halogen Bonds: The Role of the Halogen Environment.
    Bogado ML; Villafañe RN; Gómez Chavez JL; Angelina EL; Sosa GL; Peruchena NM
    J Chem Inf Model; 2022 Dec; 62(24):6494-6507. PubMed ID: 36044012
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Halogen Bonding in Nucleic Acid Complexes.
    Kolář MH; Tabarrini O
    J Med Chem; 2017 Nov; 60(21):8681-8690. PubMed ID: 28605588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Halogen bonding in complexes of proteins and non-natural amino acids.
    Borozan SZ; Stojanović SĐ
    Comput Biol Chem; 2013 Dec; 47():231-9. PubMed ID: 24200696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peptide aldehyde complexes with wheat serine carboxypeptidase II: implications for the catalytic mechanism and substrate specificity.
    Bullock TL; Breddam K; Remington SJ
    J Mol Biol; 1996 Feb; 255(5):714-25. PubMed ID: 8636973
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Binding of ligands to the active site of carboxypeptidase A.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5455-9. PubMed ID: 6946483
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thermodynamic and structural characterization of halogen bonding in protein-ligand interactions: a case study of PDE5 and its inhibitors.
    Ren J; He Y; Chen W; Chen T; Wang G; Wang Z; Xu Z; Luo X; Zhu W; Jiang H; Shen J; Xu Y
    J Med Chem; 2014 Apr; 57(8):3588-93. PubMed ID: 24702184
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biochemical and autoradiographic study of cerebral protein synthesis with [18F]-and [14C]fluorophenylalanine.
    Bodsch W; Coenen HH; Stöcklin G; Takahashi K; Hossmann KA
    J Neurochem; 1988 Mar; 50(3):979-83. PubMed ID: 3339368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 1H NMR spectroscopic characterization of binary and ternary complexes of cobalt(II) carboxypeptidase A with inhibitors.
    Bertini I; Luchinat C; Messori L; Monnanni R; Auld DS; Riordan JF
    Biochemistry; 1988 Nov; 27(22):8318-25. PubMed ID: 3242589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of aldose reductase inhibition by halogen bond tuning.
    Fanfrlík J; Kolář M; Kamlar M; Hurný D; Ruiz FX; Cousido-Siah A; Mitschler A; Rezáč J; Munusamy E; Lepšík M; Matějíček P; Veselý J; Podjarny A; Hobza P
    ACS Chem Biol; 2013 Nov; 8(11):2484-92. PubMed ID: 23988122
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amphipathic property of free thiol group contributes to an increase in the catalytic efficiency of carboxypeptidase Y.
    Mima J; Jung G; Onizuka T; Ueno H; Hayashi R
    Eur J Biochem; 2002 Jul; 269(13):3220-5. PubMed ID: 12084062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of halogen bonding in inhibitor recognition and binding by protein kinases.
    Voth AR; Ho PS
    Curr Top Med Chem; 2007; 7(14):1336-48. PubMed ID: 17692024
    [TBL] [Abstract][Full Text] [Related]  

  • 80. alpha-Methyl substrates of carboxypeptidase A. A steric probe of the active site.
    Turk J; Marshall GR
    Biochemistry; 1975 Jun; 14(12):2631-5. PubMed ID: 1148172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.